H-1B sponsorship profile: Genpharm International LLC. Across U.S. Department of Labor LCA disclosures, Genpharm International LLC filed 11 Labor Condition Applications covering 11 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 72.7% (8 certified of 11 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Genpharm International LLC’s H-1B petitions range from $121,928 at the low end to $159,185 at the high end, with a petition-weighted average of $141,259. That range reflects the mix of occupations the company sponsors, led by Senior Scientist (4 petitions at $142,441 avg), followed by Senior Scientist, Machine Learning and Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Genpharm International LLC is headquartered in Princeton, NJ under NAICS code 325411, and places H-1B workers across 1 state, most heavily in CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Genpharm International LLC ranks. By H-1B petition volume, Genpharm International LLC is #15,566 of 119,880 employers nationally and #1,331 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.